Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C288401-5mg | 5mg | In stock | $105.90 | |
C288401-10mg | 10mg | In stock | $175.90 | |
C288401-25mg | 25mg | In stock | $396.90 | |
C288401-50mg | 50mg | In stock | $739.90 | |
C288401-100mg | 100mg | In stock | $1,332.90 | |
C288401-250mg | 250mg | In stock | $2,997.90 | |
C288401-500mg | 500mg | In stock | $5,394.90 |
Selective GPR55 antagonist
Synonyms | 834903-43-4|CID-16020046|CID 16020046|CID16020046|4-[4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1,4-dihydropyrrolo[3,4-d]pyrazol-5-yl]benzoic acid|5AUY4Y2UPU|MLS000675307|SMR000314029|4-[4,6-Dihydro-4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxopyrrolo[3, |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | CID16020046 is a potent and a selective GPR55 antagonist that inhibits GPR55-mediated ERK1/2 phosphorylation. CID16020046 inhibits LPI-induced Ca2+ signaling in HEK-GPR55 cells. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of GPR55 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488199018 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488199018 |
IUPAC Name | 4-[4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1,4-dihydropyrrolo[3,4-c]pyrazol-5-yl]benzoic acid |
INCHI | InChI=1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32) |
InChi Key | VGUQVYZXABOXCX-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC=C(C=C1)C2=NNC3=C2C(N(C3=O)C4=CC=C(C=C4)C(=O)O)C5=CC(=CC=C5)O |
Isomeric SMILES | CC1=CC=C(C=C1)C2=NNC3=C2C(N(C3=O)C4=CC=C(C=C4)C(=O)O)C5=CC(=CC=C5)O |
PubChem CID | 16020046 |
Molecular Weight | 425.44 |
CAS Registry No. | 834903-43-4 |
---|---|
PubChem CID | 16020046 |
ChEMBL Ligand | CHEMBL1341792 |
Wikipedia | CID-16020046 |
GPCRdb Ligand | CID16020046 |
PubChem SID | 488199018 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2114232 | Certificate of Analysis | Jul 17, 2024 | C288401 |
J2114231 | Certificate of Analysis | Jul 17, 2024 | C288401 |
J2114230 | Certificate of Analysis | Jul 17, 2024 | C288401 |
J2114229 | Certificate of Analysis | Jul 17, 2024 | C288401 |
C2324842 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324846 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324845 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324844 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324843 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324693 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324702 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324701 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324700 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324699 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324697 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324696 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324695 | Certificate of Analysis | Feb 02, 2023 | C288401 |
C2324694 | Certificate of Analysis | Feb 02, 2023 | C288401 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 42.54, Max Conc. mM: 100 |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P264:Wash hands [and …] thoroughly after handling. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. |